Price Action Don’t Lie: What’s Propelling Rewalk Robotics Ltd to Reach Yearly Low?


Price Action Don't Lie: What's Propelling Rewalk Robotics Ltd to Reach Yearly Low?

The stock of Rewalk Robotics Ltd (NASDAQ:RWLK) hit a new 52-week low and has $5.00 target or 10.00% below today’s $5.56 share price. The 6 months bearish chart indicates high risk for the $68.15 million company. The 1-year low was reported on Oct, 17 by If the $5.00 price target is reached, the company will be worth $6.82 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 16,671 shares traded hands. Rewalk Robotics Ltd (NASDAQ:RWLK) has declined 41.58% since March 14, 2016 and is downtrending. It has underperformed by 47.19% the S&P500.

Analysts await Rewalk Robotics Ltd (NASDAQ:RWLK) to report earnings on November, 3. They expect $-0.57 EPS, down 7.55% or $0.04 from last year’s $-0.53 per share. After $-0.74 actual EPS reported by Rewalk Robotics Ltd for the previous quarter, Wall Street now forecasts -22.97% EPS growth.

Rewalk Robotics Ltd (NASDAQ:RWLK) Ratings Coverage

Out of 3 analysts covering Rewalk Robotics (NASDAQ:RWLK), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. Rewalk Robotics has been the topic of 7 analyst reports since August 10, 2015 according to StockzIntelligence Inc. Piper Jaffray initiated the shares of RWLK in a report on Friday, July 15 with “Overweight” rating. On Tuesday, September 8 the stock rating was upgraded by Zacks to “Hold”. Jefferies maintained the shares of RWLK in a report on Monday, August 10 with “Buy” rating. Zacks upgraded the stock to “Sell” rating in Tuesday, August 25 report. The firm has “Hold” rating given on Friday, August 14 by Zacks.

According to Zacks Investment Research, “ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company’s exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. ReWalk Robotics Ltd. is headquartered in Yokneam Ilit, Israel.”

More notable recent Rewalk Robotics Ltd (NASDAQ:RWLK) news were published by: which released: “SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Notifies Investors of …” on October 06, 2016, also with their article: “U.S. Department of Veterans Affairs Issues National Coverage Policy for ReWalk …” published on December 17, 2015, published: “Robbins Arroyo LLP: ReWalk Robotics Ltd. (RWLK) Misled Shareholders According …” on October 03, 2016. More interesting news about Rewalk Robotics Ltd (NASDAQ:RWLK) were released by: and their article: “INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ReWalk Robotics …” published on October 05, 2016 as well as‘s news article titled: “News ReWalk Robotics Ltd.RWLK” with publication date: September 07, 2014.

RWLK Company Profile

ReWalk Robotics Ltd., incorporated on June 20, 2001, is a medical device company. The Firm is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. It offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk creates focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. It offers various products, which include ReWalk Personal and ReWalk Rehabilitation.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply